Andrew Faller

Person

Epping Essex, GB

People

Patents Grantslast 30 patents

Information Patent Grant
2,3-dihydrofuro[2,3-b]pyridine compounds
- Patent number 11,214,576
- Issue date Jan 4, 2022
- Eli Lilly and Company
- Nicolas Jacques Francois Dreyfus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxyethylamine derivatives for the treatment of Alzheimer's disease
- Patent number 7,253,198
- Issue date Aug 7, 2007
- Glaxo Group Limited
- Emmanuel H Demont
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxyethylene compounds with Asp2 inhibitory activity
- Patent number 7,160,905
- Issue date Jan 9, 2007
- SmithKline Beecham p.l.c.
- Andrew Faller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzamide derivatives, processes for their preparation, and their p...
- Patent number 6,992,103
- Issue date Jan 31, 2006
- SmithKline Beecham p.l.c.
- Andrew Faller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxamic acid derivative as inhibitor of the formation of soluble...
- Patent number 6,673,965
- Issue date Jan 6, 2004
- SmithKline Beecham p.l.c.
- John Gerard Ward
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxamic acid derivatives as inhibitors of the production of huma...
- Patent number 6,458,779
- Issue date Oct 1, 2002
- SmithKline Beecham p.l.c.
- Andrew Faller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 6,242,467
- Issue date Jun 5, 2001
- SmithKline Beecham p.l.c.
- Andrew Faller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the production of S-CD23 and the secretion of TNF
- Patent number 6,235,753
- Issue date May 22, 2001
- SmithKline Beecham p.l.c.
- Stuart Bailey
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
2,3-DIHYDROFURO[2,3-B]PYRIDINE COMPOUNDS
- Publication number 20210070766
- Publication date Mar 11, 2021
- Eli Lilly and Company
- Nicolas Jacques Francois DREYFUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxyethylamine derivatives for the treatment of alzheimer's disease
- Publication number 20060025459
- Publication date Feb 2, 2006
- Emmanuel H Demont
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzamide derivatives, processes for their preparation, and their p...
- Publication number 20050085520
- Publication date Apr 21, 2005
- Andrew Faller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxyethylene compounds with asp2 inhibitory activity
- Publication number 20050038028
- Publication date Feb 17, 2005
- Andrew Faller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(Hetero) bicyclymethanesulfonylamino-substituted hydroxamic acid de...
- Publication number 20040225006
- Publication date Nov 11, 2004
- SmithKline Beecham plc
- Gordon Bruton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel compounds
- Publication number 20040209822
- Publication date Oct 21, 2004
- SmithKline Beecham plc
- Andrew Faller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic acid derivative as inhibitor of the formation of soluble...
- Publication number 20040077727
- Publication date Apr 22, 2004
- SmithKline Beecham plc
- John Gerard Ward
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,'3-Amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as c...
- Publication number 20030207923
- Publication date Nov 6, 2003
- Andrew Faller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid de...
- Publication number 20030199571
- Publication date Oct 23, 2003
- Gordon Bruton
- C07 - ORGANIC CHEMISTRY

Andrew Faller

Person

Patents Grantslast 30 patents

2,3-dihydrofuro[2,3-b]pyridine compounds

Hydroxyethylamine derivatives for the treatment of Alzheimer's disease

Hydroxyethylene compounds with Asp2 inhibitory activity

Benzamide derivatives, processes for their preparation, and their p...

Hydroxamic acid derivative as inhibitor of the formation of soluble...

Hydroxamic acid derivatives as inhibitors of the production of huma...

Compounds

Inhibitors of the production of S-CD23 and the secretion of TNF

Patents Applicationslast 30 patents

2,3-DIHYDROFURO[2,3-B]PYRIDINE COMPOUNDS

Hydroxyethylamine derivatives for the treatment of alzheimer's disease

Benzamide derivatives, processes for their preparation, and their p...

Hydroxyethylene compounds with asp2 inhibitory activity

(Hetero) bicyclymethanesulfonylamino-substituted hydroxamic acid de...

Novel compounds

Hydroxamic acid derivative as inhibitor of the formation of soluble...

2,'3-Amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as c...

(Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid de...